Tustumi F, Maegawa FAB, Serrano Uson Junior PL. Beyond the blank page: Frequentist and Bayesian perspectives on risk prediction algorithms. World J Gastrointest Oncol 2025; 17(12): 113988 [DOI: 10.4251/wjgo.v17.i12.113988]
Corresponding Author of This Article
Francisco Tustumi, MD, PhD, Center for Personalized Medicine, Hospital Israelita Albert Einstein, Avenue Albert Einstein, 627/701-Morumbi, São Paulo 05652900, Brazil. franciscotustumi@gmail.com
Research Domain of This Article
Surgery
Article-Type of This Article
Letter to the Editor
Open-Access Policy of This Article
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
World J Gastrointest Oncol. Dec 15, 2025; 17(12): 113988 Published online Dec 15, 2025. doi: 10.4251/wjgo.v17.i12.113988
Beyond the blank page: Frequentist and Bayesian perspectives on risk prediction algorithms
Francisco Tustumi, Felipe Antonio Boff Maegawa, Pedro Luiz Serrano Uson Junior
Francisco Tustumi, Pedro Luiz Serrano Uson Junior, Center for Personalized Medicine, Hospital Israelita Albert Einstein, São Paulo 05652900, Brazil
Francisco Tustumi, Gastroenterology, Universidade de Sao Paulo, Sao Paulo 05403-000, Brazil
Felipe Antonio Boff Maegawa, Surgery, Emory University, Atlanta, GA 30322, United States
Author contributions: Tustumi F conceived the study, designed the research question, and drafted the manuscript; Maegawa FAB contributed to the conceptual framework and critical revision of the manuscript; Uson Junior PLS contributed to the literature review and manuscript editing. All authors approved the final version of the manuscript.
Conflict-of-interest statement: There is no conflict of interest associated with any of the senior author or other coauthors contributed their efforts in this manuscript.
Open Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Francisco Tustumi, MD, PhD, Center for Personalized Medicine, Hospital Israelita Albert Einstein, Avenue Albert Einstein, 627/701-Morumbi, São Paulo 05652900, Brazil. franciscotustumi@gmail.com
Received: September 9, 2025 Revised: October 15, 2025 Accepted: November 3, 2025 Published online: December 15, 2025 Processing time: 93 Days and 23.6 Hours
Abstract
Risk prediction has long been a cornerstone of surgical oncology, enabling surgeons to anticipate complications, tailor perioperative care, and improve outcomes. With the rise of artificial intelligence, machine learning (ML) models are increasingly being applied to predict outcomes, highlighting the growing significance of data-driven methods for clinical decision-making. Currently, frequentist approaches dominate prediction models, including most ML algorithms; these rely exclusively on observed datasets and risk overlooking the cumulative value of prior clinical knowledge. In contrast, Bayesian reasoning formally integrates existing evidence with new data. In this letter, we examine the strengths of frequentist-based prediction models, discuss how Bayesian methods may improve predictive accuracy, and argue that combining both approaches offers a promising path toward more robust, interpretable, and clinically useful prediction tools in surgery. This integration can yield robust, interpretable, and clinically relevant tools that advance personalized surgical care.
Core Tip: Risk prediction in surgical oncology is evolving beyond traditional scoring systems. Frequentist methods, widely used in machine learning, offer transparency and reproducibility but rely solely on observed data. Bayesian reasoning, by contrast, integrates prior clinical knowledge with new information, mirroring real-world decision-making. The integration of both frameworks promises more reliable, interpretable, and personalized prediction tools, advancing the future of surgical care.